The “Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2023-2028” report has been added to ResearchAndMarkets.com offer.
DUBLIN, September 18, 2023 /PRNewswire/ — The global ischemic heart disease (IHD) drugs market has witnessed substantial growth, reaching 6.1 billion US dollars in 2022. Projections suggest that the market will continue to grow, with an anticipated value of 7.9 billion US dollars by 2028.
This growth corresponds to a compound annual growth rate (CAGR) of 4.4% over the forecast period 2023-2028. IHD medications are essential in the treatment and management of this condition, also known as coronary artery disease, which affects the supply of oxygen and blood to the heart.
Understanding the Ischemic Heart Disease (IHD) Drugs Market:
Ischemic heart disease (IHD), commonly known as coronary artery disease, is a disease characterized by damage to the heart muscle due to decreased oxygen and blood supply. It results from molecular changes in blood vessels or from the sudden closure and narrowing of the coronary arteries caused by atheroma. IHD is usually associated with chronic pain and discomfort in the chest, and if left untreated, it can be fatal.
IHD medications play a crucial role in the management of this condition, with various medications prescribed depending on the severity of the case. These medications include cholesterol-modifying medications, aspirin to reduce blood clotting, beta blockers to lower heart rate and blood pressure, calcium channel blockers, ranolazine, and antithrombotic agents.
Market Trends and Drivers:
Several trends and drivers are fueling the growth of the global IHD drugs market:
- Interventional medical procedures: Growing public interest in interventional medical procedures and extensive use of anti-anginal drugs to ensure cure and prevent relapses are driving the market growth.
- Awareness and prevention: Increased consumer awareness about the benefits of scheduled drug administration is influencing the demand for IHD drugs.
- Lifestyle factors: Unhealthy lifestyle habits, such as excessive alcohol consumption, smoking and physical inactivity, contribute to the increased prevalence of cardiovascular disease.
- Aging of the population: The growing global population of elderly people, who are more susceptible to heart diseases, is driving the demand for IHD drugs.
Market segmentation :
The global IHD drugs market is segmented based on disease class and drug class:
Disease class:
- Angina pectoris
- Myocardial infarction
Drug class:
- Antidyslipidemic drugs
- Calcium channel blockers
- Beta-blockers
- ACE inhibitors
- ARBs (angiotensin II receptor blockers)
- Vasodilators
- Antithrombotic agents
Regional distribution:
The market is analyzed on a regional level, covering North America (UNITED STATES And Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russiaand others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesiaand others), Latin America (Brazil, Mexicoand others), and the Middle East And Africa.
Key questions addressed:
- How has the global IHD drugs market performed and what are its growth prospects?
- What are the driving factors, constraints and opportunities in the market?
- How do these factors impact market growth?
- What are the main regional markets and countries?
- Which classes of diseases and drugs constitute the most attractive segments?
- What is the competitive landscape and who are the key market players?
Key Attributes:
|
Report attribute |
Details |
|
Number of pages |
147 |
|
Forecast period |
2022 – 2028 |
|
Estimated market value (USD) in 2022 |
$6.1 billion |
|
Projected Market Value (USD) by 2028 |
$7.9 billion |
|
Compound annual growth rate |
4.4% |
|
Regions covered |
Global |
For more information about this report, visit https://www.researchandmarkets.com/r/h7hy6q
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of market research reports and international market data. We provide you with the latest data on international and regional markets, key industries, largest companies, new products and latest trends.
Contact:
Laura Bois
Senior Manager
[email protected]
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
